M. KESKİNKILIÇ Et Al. , "Increased blood creatinine level due to CDK 4/6 inhibitor treatments: Single center experience," ANNALS OF ONCOLOGY , vol.33, 2022
KESKİNKILIÇ, M. Et Al. 2022. Increased blood creatinine level due to CDK 4/6 inhibitor treatments: Single center experience. ANNALS OF ONCOLOGY , vol.33 .
KESKİNKILIÇ, M., SEMİZ, H. S., YAVUZŞEN, T., & KARAOĞLU, A., (2022). Increased blood creatinine level due to CDK 4/6 inhibitor treatments: Single center experience. ANNALS OF ONCOLOGY , vol.33.
KESKİNKILIÇ, MERVE Et Al. "Increased blood creatinine level due to CDK 4/6 inhibitor treatments: Single center experience," ANNALS OF ONCOLOGY , vol.33, 2022
KESKİNKILIÇ, MERVE Et Al. "Increased blood creatinine level due to CDK 4/6 inhibitor treatments: Single center experience." ANNALS OF ONCOLOGY , vol.33, 2022
KESKİNKILIÇ, M. Et Al. (2022) . "Increased blood creatinine level due to CDK 4/6 inhibitor treatments: Single center experience." ANNALS OF ONCOLOGY , vol.33.
@article{article, author={MERVE KESKİNKILIÇ Et Al. }, title={Increased blood creatinine level due to CDK 4/6 inhibitor treatments: Single center experience}, journal={ANNALS OF ONCOLOGY}, year=2022}